Skip to main content

and
  1. Article

    Open Access

    ABCA7 deficiency causes neuronal dysregulation by altering mitochondrial lipid metabolism

    ABCA7 loss-of-function variants are associated with increased risk of Alzheimer’s disease (AD). Using ABCA7 knockout human iPSC models generated with CRISPR/Cas9, we investigated the impacts of ABCA7 deficiency o...

    Keiji Kawatani, Marie-Louise Holm, Skylar C. Starling in Molecular Psychiatry (2024)

  2. No Access

    Article

    Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer’s disease

    Microglial involvement in Alzheimer’s disease (AD) pathology has emerged as a risk-determining pathogenic event. While apolipoprotein E (APOE) is known to modify AD risk, it remains unclear how microglial apoE im...

    Chia-Chen Liu, Na Wang, Yuanxin Chen, Yasuteru Inoue, Francis Shue in Nature Immunology (2023)

  3. Article

    Open Access

    Deconvolution reveals cell-type-specific transcriptomic changes in the aging mouse brain

    Mounting evidence highlights the crucial role of aging in the pathogenesis of Alzheimer's disease (AD). We have previously explored human apoE-targeted replacement mice across different ages and identified dis...

    Yingxue Ren, Xue Wang, Shuwen Zhang, Hongru Hu, Zachary Quicksall in Scientific Reports (2023)

  4. Article

    Open Access

    APOE deficiency impacts neural differentiation and cholesterol biosynthesis in human iPSC-derived cerebral organoids

    The apolipoprotein E (APOE) gene is the strongest genetic risk factor for Alzheimer’s disease (AD); however, how it modulates brain homeostasis is not clear. The apoE protein is a major lipid carrier in the brain...

    **g Zhao, Tadafumi C. Ikezu, Wenyan Lu, Jesse R. Macyczko in Stem Cell Research & Therapy (2023)

  5. No Access

    Article

    Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer’s Disease

    Wnt and R-spondin (Rspo) proteins are two major types of endogenous Wnt/β-catenin signaling agonists. While Wnt/β-catenin signaling is greatly diminished in Alzheimer’s disease (AD), it remains to be elucidate...

    Jesse R. Macyczko, Na Wang, **g Zhao, Yingxue Ren, Wenyan Lu in Molecular Neurobiology (2023)

  6. No Access

    Article

    Peripheral apoE4 enhances Alzheimer’s pathology and impairs cognition by compromising cerebrovascular function

    The ε4 allele of the apolipoprotein E (APOE) gene, a genetic risk factor for Alzheimer’s disease, is abundantly expressed in both the brain and periphery. Here, we present evidence that peripheral apoE isoforms, ...

    Chia-Chen Liu, **g Zhao, Yuan Fu, Yasuteru Inoue, Yingxue Ren in Nature Neuroscience (2022)

  7. Article

    Correction to: Apolipoprotein E regulates lipid metabolism and α‑synuclein pathology in human iPSC‑derived cerebral organoids

    **g Zhao, Wenyan Lu, Yingxue Ren, Yuan Fu, Yuka A. Martens in Acta Neuropathologica (2022)

  8. Article

    Open Access

    Apolipoprotein E regulates lipid metabolism and α-synuclein pathology in human iPSC-derived cerebral organoids

    APOE4 is a strong genetic risk factor for Alzheimer’s disease and Dementia with Lewy bodies; however, how its expression impacts pathogenic pathways in a human-relevant system is not clear. Here using human iPSC-...

    **g Zhao, Wenyan Lu, Yingxue Ren, Yuan Fu, Yuka A. Martens in Acta Neuropathologica (2021)

  9. Article

    Open Access

    Author Correction: APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids

    **g Zhao, Yuan Fu, Yu Yamazaki, Yingxue Ren, Mary D. Davis in Nature Communications (2021)

  10. Article

    Open Access

    APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids

    APOE4 is the strongest genetic risk factor associated with late-onset Alzheimer’s disease (AD). To address the underlying mechanism, we develop cerebral organoid models using induced pluripotent stem cells (iPSCs...

    **g Zhao, Yuan Fu, Yu Yamazaki, Yingxue Ren, Mary D. Davis in Nature Communications (2020)

  11. Article

    Open Access

    Extensive transcriptomic study emphasizes importance of vesicular transport in C9orf72 expansion carriers

    The majority of the clinico-pathological variability observed in patients harboring a repeat expansion in the C9orf72-SMCR8 complex subunit (C9orf72) remains unexplained. This expansion, which represents the most...

    Dennis W. Dickson, Matthew C. Baker in Acta Neuropathologica Communications (2019)

  12. No Access

    Article

    Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD

    Frontotemporal lobar degeneration with neuronal inclusions of the TAR DNA-binding protein 43 (FTLD-TDP) represents the most common pathological subtype of FTLD. We established the international FTLD-TDP whole-...

    Cyril Pottier, Yingxue Ren, Ralph B. Perkerson III, Matt Baker in Acta Neuropathologica (2019)

  13. Article

    Open Access

    TMEM106B haplotypes have distinct gene expression patterns in aged brain

    Single nucleotide polymorphisms (SNPs) inherited as one of two common haplotypes at the transmembrane protein 106B (TMEM106B) locus are associated with the risk of multiple neurodegenerative diseases, including f...

    Yingxue Ren, Marka van Blitterswijk, Mariet Allen in Molecular Neurodegeneration (2018)

  14. Article

    Open Access

    Identification of missing variants by combining multiple analytic pipelines

    After decades of identifying risk factors using array-based genome-wide association studies (GWAS), genetic research of complex diseases has shifted to sequencing-based rare variants discovery. This requires l...

    Yingxue Ren, Joseph S. Reddy, Cyril Pottier, Vivekananda Sarangi in BMC Bioinformatics (2018)